Skip to content
BiomeBank logo — BiomeBank’s mission is to treat and prevent disease by resto...

BiomeBank

BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology

Founded 2018 Australia Australia 37 employees Venture round Total: $10.70M Biopharma, Biotechnology +1

General Information

Company Name BiomeBank
Founded Year 2018
Location Australia Australia
Employees 37
Industries Biopharma, Biotechnology, Manufacturing
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with BiomeBank. To contact BiomeBank, visit biomebank.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BiomeBank compare?

A PDF of BiomeBank and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BiomeBank soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BiomeBank

BiomeBank, with the slogan "BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology," is a biopharmaceutical and biotechnology startup founded in 2018. The company's focus is on manufacturing treatments and preventive measures for diseases by targeting the restoration of gut microbial ecology. BiomeBank is based in Australia and received a substantial $10.70M Venture Round investment on 08 December 2022. The investment was made by prominent firms including Ellerston Capital and the South Australian Venture Capital Fund. This latest financial backing further underscores the potential and promise of BiomeBank's innovative approach to addressing health challenges through the restoration of gut microbial balance.

Business keywords: biome, microbiome, gut health, disease prevention, microbial ecology, gut flora, microbiota, digestive health

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $10.70M 2
Ellerston Capital, South Australian Venture Capital Fund
08 Dec 2022

BiomeBank Alternatives & Competitors

View All Alternatives
BiomeBank vs

Engineering Living Medicines for Chronic Diseases

Series B
1 employees
Biopharma, Biotechnology
BiomeBank vs
ClostraBio, Inc
ClostraBio, Inc United States

ClostraBio is dedicated to creating new dietary supplements and therapeutics for gut health, IBD and...

Series A
13 employees
Biopharma, Biotechnology
BiomeBank vs

Crossing the next frontier, to give you a fair chance to fight

Seed
8 employees
Biopharma, Biotechnology

FAQ About BiomeBank

BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
BiomeBank was founded in 2018.
BiomeBank is headquartered in Australia.
BiomeBank operates in Biopharma, Biotechnology and Manufacturing. Its work centres on biome, microbiome, gut health and disease prevention.
BiomeBank has approximately 37 employees.
BiomeBank has completed 1 funding round, raising a total of $10.70M. The latest funding stage is Venture round.
Top alternatives and competitors to BiomeBank include Novome Biotechnologies, ClostraBio, Inc, Exeliom Biosciences, A-Mansia Biotech, Concerto Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BiomeBank and Novome Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BiomeBank, https://bouncewatch.com/company/biomebank, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout